Stay updated on Pembrolizumab Post-ASCT in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Post-ASCT in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Post-ASCT in Lymphoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Reid Merryman, MD has been added to the investigators list (noted on 2026-05-18 and 2026-05-04) and Philippe Armand, MD, PhD has been removed (noted on 2026-02-12, 2026-01-26, and 2023-07).
    Difference
    0.4%
    Check dated 2026-05-25T08:14:34.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.5.3 to v3.5.4, signaling a minor build/version update. This change represents an update to the page's revision history without altering visible content or user interactions.
    Difference
    0.1%
    Check dated 2026-05-18T04:00:35.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    This change updates the page’s system/release revision label from v3.5.2 to v3.5.3, without altering the study record content.
    Difference
    0.1%
    Check dated 2026-04-26T15:16:14.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. No substantive changes to content or features.
    Difference
    0.1%
    Check dated 2026-04-19T12:47:06.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0; previous revision v3.4.3 has been removed.
    Difference
    0.1%
    Check dated 2026-03-21T08:37:55.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    The page shows a revision from v3.4.2 to v3.4.3. This appears to be a minor update with no changes to study content.
    Difference
    0.1%
    Check dated 2026-03-06T18:42:56.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Post-ASCT in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Post-ASCT in Lymphoma Clinical Trial page.